Document is current

Article History

First Online: 23 April 2015

Competing interests

: D.S. and A. Hauschild declare an association with the following companies: Amgen, Bristol–Myers Squibb, Genentech, GlaxoSmithKline, Merck/MSD, Novartis, Pfizer, Boehringer Ingelheim and Roche. C.G. declares personal fees from Amgen, Merck/MSD and Novartis, and declares grants and personal fees from Bristol–Myers Squibb, GlaxoSmithKline and Roche outside of the submitted work. A. Roesch has received travel grants and honoraria from Roche and TEVA, and research grants from Novartis. M.A.M. has received honoraria from Next Meeting Generation for speaking on the topic of dermoscopy at the American Dermoscopy Meeting. A. Halpern serves as a consultant to Caliber Imaging and Diagnostics, Canfield Scientific, DermTech and SciBase AB, and serves on the data safety and monitoring board of Quintiles and Janssen Research and Development LLC. J.-J.G. has received fees for advisory boards and lectures from Amgen, GlaxoSmithKline, MSD, Novartis and Roche, and has received research grants from Bristol–Myers Squibb and Roche. J.E.G. serves on the global advisory board for Merck. A. Ribas has served as consultant for Amgen, Astellas, Genentech-Roche, GlaxoSmithKline, Merck, Novartis and Pierre Fabre, and serves on the scientific advisory board and has stock options for Compugen, Flexus Biosciences and Kite Pharma. G.M. has received consulting income from Provectus, and has received research support from Celgene and Pfizer. M.H. and D.E.F. declare no competing interests.